AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%
AbbVie Inc.’s stock rose 5% early Friday to lead S&P 500 gainers premarket, after the drug company beat fourth-quarter ...
FierceBiotech2d
Eli Lilly's next R&D focus: Testing incretin meds in neuro, immunology fields
Eli Lilly has invested heavily into obesity, dominating the landscape—alongside semaglutide maker Novo Nordisk—with its ...
FiercePharma2d
Regeneron tangles with Sanofi over commercial transparency in long-running Dupixent collaboration
Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...
An unexpected mechanism regulates the immune response during parasitic infections
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune ...
Investor's Business Daily on MSN8d
AbbVie Surges 8% As Immunology Powerhouses Skyrizi And Rinvoq Continue To Dominate
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq ...
FiercePharma3d
TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
生物谷2d
Nature Immunology：卢伟强/刘明耀团队发现肿瘤免疫新机制，并找到潜在治疗药物
华东师范大学生命科学学院卢伟强研究员和刘明耀教授团队合作，在 Nature Immunology 期刊发表了题为： The lactate receptor HCAR1 drives the recruitment of ...
Science Daily4d
Molecular basis of food allergy
A multi-institutional study has identified one of the allergens responsible for eosinophilic esophagitis (EoE), an inflammatory disease of the esophagus. This is the first time one of the allergens ...